FDA Inspection 844112 — Brigham And Women's Hospital

Brigham And Women's Hospital — FEI 1270016

The FDA completed an inspection of Brigham And Women's Hospital on August 13, 2013 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 13, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Boston, MA (United States)